Stage IVA Prostate Cancer AJCC v8 Recruiting Phase 3 Trials for Triptorelin (DB06825)

IndicationStatusPhase
DBCOND0109674 (Stage IVA Prostate Cancer AJCC v8)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04513717Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT TrialTreatment
NCT03678025Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate CancerTreatment